NSE
Jubilant Pharmova LimitedJUBLPHARMA
Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a 14% rise in FY26 revenue but saw its net profit fall by 52%. The company's financial performance has been mixed, affecting its stock market performance.
| Key products | Pharmaceuticals |
|---|---|
| Geography | India |
| Competitors | Main listed competitors not specified with certainty; however, the pharmaceutical sector in India includes companies like Dr. Reddy’s Laboratories and Cipla. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹348.4 Cr
Institutional buyers
3 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 5 Per Share
ex 2026-07-24
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | JUBLPHARMAThis | — | — | — | — | +2 | 6 |
| 2 | ACMESOLAR | — | — | — | — | +3 | 6 |
| 3 | AADHARHFC | — | — | — | — | — | — |
| 4 | AARTIIND | — | — | — | — | — | — |
| 5 | ACE | — | — | — | — | — | — |
| 6 | ACUTAAS | — | — | — | — | +4 | 6 |
| 7 | ABLBL | — | — | — | — | — | — |
| 8 | AAVAS | −₹1.9 Cr | 2 | — | — | — | — |
| 9 | ABFRL | −₹142.6 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-07-24ActionDividend - Rs 5 Per ShareDividend
- 2026-05-25NewsJubilant Pharmova FY26 revenue rises 14%; PAT grows 7%scanx.trade
- 2026-05-22NewsJubilant Pharmova FY26 Net Profit Falls 52% to ₹3,975Mscanx.trade
- 2026-02-04NewsAre Jubilant Pharmova Limited's (NSE:JUBLPHARMA) Mixed Financials The Reason For Its Gloomy Performance on Thesimplywall.st
- 2025-10-31NewsJubilant Pharmova Q2FY26 PAT Rises 21% to ₹124 Cr; Revenue Up 12%HDFC Sky
- 2025-09-18NewsJubilant Pharmova Limited's (NSE:JUBLPHARMA) top owners are private companies with 50% stake, while 22% is helsimplywall.st
- 2022-01-07NewsJubilant Pharmova Share Price Today - Live NSE/BSEICICI Direct
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
No scored filings for JUBLPHARMA yet.
No bulk/block deals for JUBLPHARMA in this window.
News & chatter on JUBLPHARMA
RSS News
6▲scanx.trade · 25/5/2026
scanx.trade · 22/5/2026
simplywall.st · 4/2/2026
▲HDFC Sky · 31/10/2025
simplywall.st · 18/9/2025
ICICI Direct · 8/1/2022
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.